Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| ALGN | ALIGN TECHNOLOGY INC | 2026-03-03 12:09:39 | 181.32 | -7.7 | -4.07 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALGN | 0001097149 | ALIGN TECHNOLOGY INC | US0162551016 | 549300N5YSE0U3LCP840 | 943267295 | Nasdaq | 3842 | Orthopedic, Prosthetic & Surgical Appliances & Supplies | 1231 | DE | 410 NORTH SCOTTSDALE ROAD, SUITE 1300 | TEMPE | AZ | 85288 | UNITED STATES | US | 408-470-1000 | 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, AZ, 85288 | 410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, AZ, 85288 | — | Orthodontics | 1997 | Joe Hogan | 20,945 | https://aligntech.com | 12,900,000,000 | 72,040,000 | 71,749,995 | Align Technology, Inc. is an American manufacturer of 3D digital scanners and Invisalign clear aligners used in orthodontics and restorative workflow. It was founded in 1997 and is headquartered in Tempe, Arizona. The company manufactures the aligners in Juarez, Mexico, and its scanners in Israel and China. The company is best known for its Invisalign system, which is a clear aligner treatment used to straighten teeth. | 2026-02-26 15:59:26 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 12,900,000,000 | -800,000,000 | -5.8394 | 73,597,648 | -1,506,484 | -2.0059 |
| 2023 | 13,700,000,000 | 400,000,000 | 3.0075 | 75,104,132 | -1,506,187 | -1.966 |
| 2022 | 13,300,000,000 | -21,400,000,000 | -61.6715 | 76,610,319 | -2,185,175 | -2.7732 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Emory Wright | Executive Vice President | 2024 | 568,462 | — | 3,374,459 | 419,000 | 11,499 | 4,373,420 |
| Julie Coletti | Executive Vice President | 2024 | 597,692 | — | 3,749,021 | 441,000 | 11,502 | 4,799,215 |
| Joseph M. Hogan | Chief Executive Officer, President | 2024 | 1,396,904 | — | 23,848,513 | 2,058,000 | 17,762 | 27,321,179 |
| John F. Morici | Chief Financial Officer, Executive Vice President | 2024 | 675,385 | — | 5,249,435 | 500,000 | 11,567 | 6,436,387 |
| Stuart Hockridge | Executive Vice President | 2024 | 518,462 | — | 2,624,717 | 382,000 | 18,398 | 3,543,577 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 20,290 |
| 2024 | 20,945 |
| 2023 | 21,610 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 4,034,964,000 | 3,999,012,000 | 3,862,260,000 |
| Cost Of Revenue | 1,323,951,000 | 1,199,853,000 | 1,155,397,000 |
| Gross Profit | 2,711,013,000 | 2,799,159,000 | 2,706,863,000 |
| Research And Development Expenses | 369,911,000 | 364,202,000 | 346,830,000 |
| General And Administrative Expenses | 1,755,791,000 | 1,763,193,000 | 1,703,379,000 |
| Operating Expenses | 2,165,258,000 | 2,191,531,000 | 2,063,525,000 |
| Operating Income | 545,755,000 | 607,628,000 | 643,338,000 |
| Net Income | 410,351,000 | 421,362,000 | 445,053,000 |
| Earnings Per Share Basic | 5.66 | 5.63 | 5.82 |
| Earnings Per Share Diluted | 5.65 | 5.62 | 5.81 |
| Weighted Average Shares Outstanding Basic | 72,542,000 | 74,877,000 | 76,426,000 |
| Weighted Average Shares Outstanding Diluted | 72,588,000 | 74,993,000 | 76,568,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 1,094,908,000 | 1,043,887,000 | 937,438,000 |
| Marketable Securities Current | — | 0 | 35,304,000 |
| Accounts Receivable | 47,900,000 | 52,100,000 | 51,200,000 |
| Inventories | 226,343,000 | 254,287,000 | 296,902,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 47,274,000 | 81,576,000 | 77,335,000 |
| Total Assets Current | 2,616,562,000 | 2,492,441,000 | 2,446,618,000 |
| Marketable Securities Non Current | — | 0 | 8,022,000 |
| Property Plant And Equipment | 1,131,453,000 | 1,271,134,000 | 1,290,863,000 |
| Other Assets Non Current | 278,048,000 | 234,159,000 | 128,682,000 |
| Total Assets Non Current | 1,239,775,000 | 1,384,510,000 | 1,408,862,000 |
| Total Assets | 6,233,693,000 | 6,214,600,000 | 6,083,877,000 |
| Accounts Payable | 121,450,000 | 108,693,000 | 113,125,000 |
| Deferred Revenue | 1,261,816,000 | 1,331,146,000 | 1,427,706,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 536,749,000 | 598,188,000 | 525,780,000 |
| Total Liabilities Current | 1,920,015,000 | 2,038,027,000 | 2,066,611,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 113,824,000 | 139,908,000 | 173,065,000 |
| Total Liabilities Non Current | 264,531,000 | 324,588,000 | 386,777,000 |
| Total Liabilities | 2,184,546,000 | 2,362,615,000 | 2,453,388,000 |
| Common Stock | 7,000 | 7,000 | 7,000 |
| Retained Earnings | 2,464,157,000 | 2,483,766,000 | 2,447,174,000 |
| Accumulated Other Comprehensive Income | 75,388,000 | 5,978,000 | 21,168,000 |
| Total Shareholders Equity | 4,049,147,000 | 3,851,985,000 | 3,630,489,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 237,436,000 | 145,034,000 | 142,401,000 |
| Share Based Compensation Expense | 185,870,000 | 173,703,000 | 154,026,000 |
| Other Non Cash Income Expense | -37,686,000 | -12,256,000 | -32,733,000 |
| Change In Accounts Receivable | 139,909,000 | 153,487,000 | 104,614,000 |
| Change In Inventories | -808,000 | -25,053,000 | -30,169,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 5,330,000 | -843,000 | -7,703,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 593,223,000 | 738,231,000 | 785,776,000 |
| Purchases Of Marketable Securities | 0 | 0 | 2,910,000 |
| Sales Of Marketable Securities | 0 | 18,193,000 | 6,234,000 |
| Acquisition Of Property Plant And Equipment | 102,445,000 | 115,580,000 | 177,716,000 |
| Acquisition Of Business | 0 | 77,075,000 | 0 |
| Other Investing Activities | 0 | -235,000 | -278,000 |
| Cash From Investing Activities | -112,445,000 | -254,912,000 | -195,943,000 |
| Tax Withholding For Share Based Compensation | 20,390,000 | 28,125,000 | 22,575,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | 21,749,000 | 25,281,000 | 26,595,000 |
| Repurchase Of Common Stock | 465,939,000 | 352,878,000 | 592,360,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -464,580,000 | -355,722,000 | -598,340,000 |
| Change In Cash | 51,223,000 | 106,444,000 | -3,836,000 |
| Cash At End Of Period | 1,094,908,000 | 1,043,887,000 | 937,438,000 |
| Income Taxes Paid | 134,753,000 | 177,082,000 | 294,569,000 |
| Interest Paid | — | — | — |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | 5.66 | 5.63 | 5.82 |
| Price To Earnings Ratio | 27.5883 | 37.0355 | 47.079 |
| Earnings Growth Rate | 0.5329 | -3.2646 | 25.974 |
| Price Earnings To Growth Ratio | 51.7741 | -11.3446 | 1.8125 |
| Book Value Per Share | 55.818 | 51.4442 | 47.5033 |
| Price To Book Ratio | 2.7975 | 4.0531 | 5.768 |
| Ebitda | 782,540,000 | 743,478,000 | 882,023,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 97,755,000 | 125,305,000 | 201,409,000 |
| Free Cash Flow | 495,468,000 | 612,926,000 | 584,367,000 |
| Return On Equity | 0.1013 | 0.1094 | 0.1226 |
| One Year Beta | 1.2423 | 1.4193 | 1.9675 |
| Three Year Beta | 1.4559 | 1.6641 | 1.6981 |
| Five Year Beta | 1.5486 | 1.5484 | 1.5636 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Morici John | EVP, CHIEF FINANCIAL OFFICER | 2026-02-20 | 4,653 | D | 0 |
| Morici John | EVP, CHIEF FINANCIAL OFFICER | 2026-02-20 | 718 | D | 718 |
| HOGAN JOSEPH M | Director, President and CEO | 2026-02-20 | 40,248 | A | 225,377 |
| HOGAN JOSEPH M | Director, President and CEO | 2026-02-20 | 16,107 | D | 209,270 |
| HOGAN JOSEPH M | Director, President and CEO | 2026-02-20 | 19,144 | A | 19,144 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Daniel S Sullivan | Senator | 2023-09-22 | Sale (Full) | 2023-08-22 | Joint | $1,001 - $15,000 |
| Daniel S Sullivan | Senator | 2023-09-18 | Sale (Full) | 2023-08-22 | Joint | $1,001 - $15,000 |
| Daniel S Sullivan | Senator | 2023-02-13 | Purchase | 2023-01-10 | Joint | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2022-11-10 | Sale (Full) | 2022-10-05 | Joint | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2021-07-23 | Purchase | 2021-03-29 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Lisa McClain | 2025-10-22 | MI09 | Sale | 2025-09-11 | Spouse | $1,001 - $15,000 |
| Lisa McClain | 2025-09-12 | MI09 | Purchase | 2025-08-04 | Spouse | $1,001 - $15,000 |
| Rob Bresnahan | 2025-05-08 | PA08 | Sale | 2025-04-08 | — | $1,001 - $15,000 |
| Rob Bresnahan | 2025-03-27 | PA08 | Purchase | 2025-02-25 | — | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-03-06 | CA31 | Sale | 2025-02-26 | — | $1,001 - $15,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| TOBAM | 2025-12-31 | 30,000 | 192 | 156.25 |
| Banque Transatlantique SA | 2025-12-31 | 4,528 | 29 | 156.1379 |
| Bell Investment Advisors, Inc | 2025-12-31 | 2,811 | 18 | 156.1667 |
| Pacer Advisors, Inc. | 2025-12-31 | 867,569 | 5,556 | 156.1499 |
| MV CAPITAL MANAGEMENT, INC. | 2025-12-31 | 5,622 | 36 | 156.1667 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Lazard Active ETF Trust | 2025-12-31 | Lazard US Systematic Small Cap Equity ETF | SYZ | 1,411 | 220,327.65 | 0.3985 |
| PIMCO Equity Series | 2025-12-31 | Class A | PKAAX | 14,759 | 2,304,617.85 | 0.1738 |
| PIMCO Equity Series | 2025-12-31 | I-2 | PKAPX | 14,759 | 2,304,617.85 | 0.1738 |
| PIMCO Equity Series | 2025-12-31 | Institutional Class | PKAIX | 14,759 | 2,304,617.85 | 0.1738 |
| Advisor Managed Portfolios | 2025-12-31 | Optimize Strategy Index ETF | OPTZ | 3,097 | 483,596.55 | 0.2414 |